| # | Title | Journal | Year | Citations |
|---|
| 1 | suPAR: The Molecular Crystal Ball | Disease Markers | 2009 | 657 |
| 2 | Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database | Disease Markers | 2004 | 416 |
| 3 | Long Noncoding RNAs as Biomarkers in Cancer | Disease Markers | 2017 | 309 |
| 4 | Shotgun Proteomics and Biomarker Discovery | Disease Markers | 2002 | 299 |
| 5 | Altered Glutathione Redox State in Schizophrenia | Disease Markers | 2006 | 291 |
| 6 | Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI-TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer | Disease Markers | 2001 | 278 |
| 7 | The Epidemiology of Human Papillomavirus Infection and Cervical Cancer | Disease Markers | 2007 | 274 |
| 8 | suPAR: the molecular crystal ball | Disease Markers | 2009 | 254 |
| 9 | Development of a Fluorescent Multiplex Assay for Detection of MSI-High Tumors | Disease Markers | 2004 | 234 |
| 10 | Early Detection of Ovarian Cancer | Disease Markers | 2007 | 223 |
| 11 | Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics | Disease Markers | 2016 | 213 |
| 12 | Rheumatoid Factors: Clinical Applications | Disease Markers | 2013 | 211 |
| 13 | Glycosylation of Serum Proteins in Inflammatory Diseases | Disease Markers | 2008 | 209 |
| 14 | Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk | Disease Markers | 2015 | 208 |
| 15 | Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers | Disease Markers | 2013 | 201 |
| 16 | Biomarker Amplification by Serum Carrier Protein Binding | Disease Markers | 2003 | 195 |
| 17 | Systematic Review on Resting-State EEG for Alzheimer’s Disease Diagnosis and Progression Assessment | Disease Markers | 2018 | 195 |
| 18 | Single-Cell Elastography: Probing for Disease with the Atomic Force Microscope | Disease Markers | 2004 | 190 |
| 19 | The Role of RASSF1A Methylation in Cancer | Disease Markers | 2007 | 183 |
| 20 | Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer | Disease Markers | 2009 | 178 |
| 21 | Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia | Disease Markers | 2015 | 178 |
| 22 | Biomarkers in Cervical Cancer Screening | Disease Markers | 2007 | 175 |
| 23 | Ultrasound-Mediated Biophotonic Imaging: A Review of Acousto-Optical Tomography and Photo-Acoustic Tomography | Disease Markers | 2004 | 174 |
| 24 | Oxidative Stress-Related Biomarkers in Essential Hypertension and Ischemia-Reperfusion Myocardial Damage | Disease Markers | 2013 | 174 |
| 25 | Novel, Non-Radioactive, Simple and Multiplex PCR-cRFLP Methods for Genotyping Human SP-A and SP-D Marker Alleles | Disease Markers | 1999 | 169 |
| 26 | Human Papillomaviruses and Non-Melanoma Skin Cancer: Basic Virology and Clinical Manifestations | Disease Markers | 2007 | 162 |
| 27 | Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis | Disease Markers | 2008 | 161 |
| 28 | Acute phase proteins as disease markers | Disease Markers | 1987 | 160 |
| 29 | Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease | Disease Markers | 2015 | 158 |
| 30 | Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases | Disease Markers | 2017 | 158 |
| 31 | Near-Infrared Diffuse Optical Tomography | Disease Markers | 2002 | 153 |
| 32 | Serum circulating microRNA profiling for identification of potential breast cancer biomarkers | Disease Markers | 2013 | 152 |
| 33 | Altered Glycosylation in Tumours Focused to Cancer Diagnosis | Disease Markers | 2008 | 147 |
| 34 | Quasimonomorphic Mononucleotide Repeats for High-Level Microsatellite Instability Analysis | Disease Markers | 2004 | 146 |
| 35 | Protein Analysis in Human Cerebrospinal Fluid: Physiological Aspects, Current Progress and Future Challenges | Disease Markers | 2006 | 142 |
| 36 | Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers | Disease Markers | 2018 | 131 |
| 37 | A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology | Disease Markers | 2016 | 130 |
| 38 | Papillomavirus Life Cycle Organization and Biomarker Selection | Disease Markers | 2007 | 129 |
| 39 | MicroRNA Microarray Expression Profiling in Human Myocardial Infarction | Disease Markers | 2009 | 126 |
| 40 | Molecular Markers for Breast Cancer: Prediction on Tumor Behavior | Disease Markers | 2014 | 126 |
| 41 | Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer | Disease Markers | 2009 | 126 |
| 42 | A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines | Disease Markers | 2001 | 123 |
| 43 | The Relationship between Clinical Feature, Complex Immunophenotype, Chromosome Karyotype, and Outcome of Patients with Acute Myeloid Leukemia in China | Disease Markers | 2015 | 120 |
| 44 | Overview of Biomarkers and Surrogate Endpoints in Drug Development | Disease Markers | 2002 | 117 |
| 45 | Genetic Markers for PTSD Risk and Resilience Among Survivors of the World Trade Center Attacks | Disease Markers | 2011 | 117 |
| 46 | Colorectal Carcinogenesis: MSI-H Versus MSI-L | Disease Markers | 2004 | 116 |
| 47 | Increased Frequency of the Uncommon Allele of a Tumour Necrosis Factor Alpha Gene Polymorphism in Rheumatoid Arthritis and Systemic Lupus Erythematosus | Disease Markers | 1994 | 115 |
| 48 | Biomarkers in Schizophrenia: A Brief Conceptual Consideration | Disease Markers | 2013 | 115 |
| 49 | Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analyses | Disease Markers | 2016 | 114 |
| 50 | Clinical Significance of Inflammatory Markers in Polycystic Ovary Syndrome: Their Relationship to Insulin Resistance and Body Mass Index | Disease Markers | 2009 | 111 |
